Cancer Prevention Institute of California

Recent papers from Cancer Prevention Institute of California

1. Hispanic and Asian American/Pacific Islander ethnic enclave, neighborhood socioeconomic status, and renal cell carcinoma incidence in CaliforniaCancer Epidemiology Biomarkers & Prevention · 2026
2. Communication Challenges and Strategies in Adolescent and Young Adult Cancer Survivorship Care: A Qualitative Study of Clinician PerspectivesJournal of Adolescent and Young Adult Oncology · 2026
3. Efficacy and safety of anti-PD-1 combined with IFN-α1b with or without anlotinib as the first-line therapy in patients with unresectable advanced melanoma: a real-world cohort studyCancer Immunology Immunotherapy · 2026
4. Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell LymphomasBlood · 2026
5. Synthetic transcription factors designed by domain recombination enhance CAR T cell antitumor functionCell · 2026
6. Beyond amplification: precision approaches to targeting HER2Clinical Cancer Research · 2026
7. Lumpectomy Margins and Local Recurrence in DCISJAMA Surgery · 2026
8. Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global ImplementationJournal of Clinical Oncology · 2026
9. Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery PlatformBioconjugate Chemistry · 2026
10. A phase 1 study of PHST001, an anti-CD24 monoclonal antibody, in adult patients with advanced relapsed and/or refractory solid tumors.Journal of Clinical Oncology · 2026
11. Insights from an artificial intelligence (AI)–powered cancer navigation platform: Digital support and treatment decision confidence.Journal of Clinical Oncology · 2026
12. Using large language models to extract diagnosis, recurrence, and death dates from breast cancer electronic medical records.Journal of Clinical Oncology · 2026
13. NRG-HN006: Randomized phase II/III trial of sentinel lymph node biopsy versus elective neck dissection for early-stage oral cavity cancer.Journal of Clinical Oncology · 2026
14. Adjuvant erlotinib versus observation after complete resection of EGFR -mutant NSCLC: Final overall survival results of Alliance A081105.Journal of Clinical Oncology · 2026
15. Spatial organization of immune surveillance by germline mutation status in the Breast Cancer Family Registry.Journal of Clinical Oncology · 2026
16. The molecular basis for nuclear pore destruction by a proximity-inducing molecular glueCell chemical biology · 2026
17. Immune-related adverse event severity and clinical outcomes with immune checkpoint inhibitor immunotherapy in participants with non–small cell lung cancer: Analysis of the lung MAP sub-studies S1400A, S1400I, S1400F, and S1800A.Journal of Clinical Oncology · 2026
18. Pooled analyses of clinical outcomes with afamitresgene autoleucel (afami-cel) in metastatic synovial sarcoma.Journal of Clinical Oncology · 2026
19. Circulating tumor DNA monitoring for early detection of disease recurrence in bone/soft tissue sarcoma.Journal of Clinical Oncology · 2026
20. Correlates of patient enrollment in a population-based randomized controlled trial of cascade genetic testing in families with hereditary cancer susceptibility.Journal of Clinical Oncology · 2026